Head-to-head · Cost-Efficiency Index
CoreAge Rx vs PeptidesRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxPeptidesRx
Cost-first shoppers who want itemized per-vial pricing across every dose tier, for shoppers who read past the '1-week starter' teaser price.
Visit PeptidesRxThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 55. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. PeptidesRx still earns a C — Cost-first shoppers who want itemized per-vial pricing across every dose tier, for shoppers who read past the '1-week starter' teaser price.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | PeptidesRx |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 55/100 |
| Semaglutide / mo | $99/mo | $321/mo (10 mg dose, compounded) |
| Tirzepatide / mo | $149/mo | $576/mo (40 mg dose, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $3,852 |
| Tirzepatide / yr (modeled) | $1,788 | $6,912 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #1 | #343 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 381 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
PeptidesRx
55/100Where the value is
- Confirmed legitimate clinical telehealth service — licensed provider consultation required before any prescription, with no 'research use only' disclaimer anywhere
- Every dose tier for both drugs is individually priced and published, more granular transparency than most competitors in this batch
- Cancel-anytime, no long-term contract on any SKU
The tradeoffs
- The homepage's 'From $185/mo' and 'From $304/mo' teaser prices are for vials the catalog itself labels a '1-week starter' supply — the genuine 4-week tier costs 69-89% more, and this gap is easy to miss since every tier bills as a monthly auto-renewal regardless of the vial's actual duration
- No compounding pharmacy is individually named, only 'PCAB-accredited US pharmacies'
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.